Literature DB >> 9410641

[Early detection of threatened implant loss in tumor patients].

T Weischer1, C Mohr.   

Abstract

After resection of an oropharyngeal tumor, 157 dental implants were placed in 17 irradiated (44 Gy on average) and 20 non-irradiated patients. Within a control period of 37 months, 15 implants had failed. The reason for implant failure was analyzed, whereby indicative parameters were revealed. Eleven implants in four irradiated and one non-irradiated oral cancer patients showed no primary osseointegration during the healing period because of mandible fracture, overloading or for unknown reasons. Four implants in one irradiated and three non-irradiated oral-cancer patients were lost subsequently on average 39 months after second-stage surgery due to biomechanical overloading or bacterial infection. No osteoradionecrosis development due to implant failure was observed in irradiated patients. In all cases, peri-implant pocket depth, implant stability and peri-implant bone resorption increased before definitive implant failure. Therefore, these findings seem to be useful as indicative parameters in the prediction of implant failure.

Entities:  

Mesh:

Year:  1997        PMID: 9410641     DOI: 10.1007/BF03043570

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  19 in total

1.  Concept of surgical and implant-supported prostheses in the rehabilitation of patients with oral cancer.

Authors:  T Weischer; D Schettler; C Mohr
Journal:  Int J Oral Maxillofac Implants       Date:  1996 Nov-Dec       Impact factor: 2.804

2.  A Japanese multicenter study of osseointegrated implants placed in irradiated tissues: a preliminary report.

Authors:  A Niimi; T Fujimoto; Y Nosaka; M Ueda
Journal:  Int J Oral Maxillofac Implants       Date:  1997 Mar-Apr       Impact factor: 2.804

3.  Oral implant rehabilitation of patients with oral malignancies treated with radiotherapy and surgery without adjunctive hyperbaric oxygen.

Authors:  L Franzén; J B Rosenquist; K I Rosenquist; I Gustafsson
Journal:  Int J Oral Maxillofac Implants       Date:  1995 Mar-Apr       Impact factor: 2.804

4.  Osteointegration of implants in radiated bone with and without adjunctive hyperbaric oxygen.

Authors:  P E Larsen; M J Stronczek; F M Beck; M Rohrer
Journal:  J Oral Maxillofac Surg       Date:  1993-03       Impact factor: 1.895

5.  A new concept in the treatment of osteoradionecrosis.

Authors:  R E Marx
Journal:  J Oral Maxillofac Surg       Date:  1983-06       Impact factor: 1.895

6.  Histomorphometric examination of healing around hydroxylapatite implants in 60Co-irradiated bone.

Authors:  Y Matsui; K Ohno; K Michi; T Tachikawa
Journal:  J Oral Maxillofac Surg       Date:  1994-02       Impact factor: 1.895

7.  Soft tissue reaction to de novo plaque formation on implants and teeth. An experimental study in the dog.

Authors:  T Berglundh; J Lindhe; C Marinello; I Ericsson; B Liljenberg
Journal:  Clin Oral Implants Res       Date:  1992-03       Impact factor: 5.977

8.  Microbial aspects of failing osseointegrated dental implants in humans.

Authors:  G A Alcoforado; T E Rams; D Feik; J Slots
Journal:  J Parodontol       Date:  1991-02

9.  Treatment of peri-implantitis using guided bone regeneration and bone grafts, alone or in combination, in beagle dogs. Part 1: Clinical findings and histologic observations.

Authors:  M B Hürzeler; C R Quiñones; E C Morrison; R G Caffesse
Journal:  Int J Oral Maxillofac Implants       Date:  1995 Jul-Aug       Impact factor: 2.804

10.  Evaluation of osseointegration of endosseous implants in radiated, vascularized fibula flaps to the mandible: a pilot study.

Authors:  H D Barber; R J Seckinger; R E Hayden; G S Weinstein
Journal:  J Oral Maxillofac Surg       Date:  1995-06       Impact factor: 1.895

View more
  1 in total

Review 1.  Survival of dental implants and occurrence of osteoradionecrosis in irradiated head and neck cancer patients: a systematic review and meta-analysis.

Authors:  Daniel Jan Toneatti; Ronny Roger Graf; John-Patrik Burkhard; Benoît Schaller
Journal:  Clin Oral Investig       Date:  2021-08-16       Impact factor: 3.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.